NHS Bath and North East Somerset, Swindon and Wiltshire CCG Royal United Hospitals Bath NHS Foundation Trust Great Western Hospitals NHS Foundation Trust Salisbury NHS Foundation Trust
Formulary Chapter 20: Unlicensed Medicines / Significant off-label use - Full Chapter
Notes:
Where possible, we have indicated unlicensed medicines and significant off label use within the relevant clinical chapters of this formulary.
This chapter of the BSW Formulary contains entries for medicines which are not included in the current BNF, and which cannot be classified under the BNF chapter system.
Details...
20
Unlicensed Medicines
Acetic acid 5%
Unlicensed
GWH Obstetric and Gynae OP stock
Ajmaline
Unlicensed
For use within RUH
Approved for use in the diagnosis of Brugada syndrome (unlicensed) by Consultant Cardiologists (for diagnostic use only).
Biolon / Haelonid AV
Unlicensed
For use within SFT
Cyanoacrylate glue N-butyl-2-cyanoacrylate
Unlicensed
For use within the RUH
For treatment of gastric variceal bleeding
Fibrin Sealant
(Tisseel®)
Unlicensed
For use within RUH and GWH only
Heavy Liquid (Perfluorodecalin)
Unlicensed
For use within GWH only
Indigo carmine solution
Unlicensed
For use within RUH
'Off label' use of solution for injection as replacement for unlicensed preparation in endoscopy
RED - Hospital only – to be prescribed by a specialist and supplied from secondary care ONLY throughout treatment.
Amber medicines are considered suitable for GP prescribing following specialist initiation or recommendation.
Shared Care - these medicines require specialist initiation and stabilisation. Ongoing division of responsibility for drug and disease monitoring between specialist and GP by a Shared Care Guideline (SCG). If no SCG in place status reverts to red.
These medicines are appropriate for initiation in both primary and secondary care. Prescribing is appropriate within licensed or local recommendations.
Suitable for patient to be directed to buy themselves
Not currently used. We intend to include this TLS in future to highlight where a decision to use this medicine is under review.
(In use from Oct 2020) Used where a decision has been made by the BSW APC not to routinely commission this preparation for its licensed indications. Do not prescribe.
Not currently used. We intend to include this TLS in future to highlight where this medicine and indication is ONLY available through a Specialist Centre according to a NICE Highly Specialised Technology or NHSE Specialised Commission Circular / Policy.